Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial
Crossref DOI link: https://doi.org/10.1007/s00520-015-2714-9
Published Online: 2015-04-08
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bakhshi, Sameer
Batra, Atul
Biswas, Bivas
Dhawan, Deepa
Paul, Reeja
Sreenivas, Vishnubhatla
Text and Data Mining valid from 2015-04-08